1. Home
  2. PCYO vs LUNG Comparison

PCYO vs LUNG Comparison

Compare PCYO & LUNG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PCYO
  • LUNG
  • Stock Information
  • Founded
  • PCYO 1976
  • LUNG 1995
  • Country
  • PCYO United States
  • LUNG United States
  • Employees
  • PCYO N/A
  • LUNG N/A
  • Industry
  • PCYO Water Supply
  • LUNG Industrial Specialties
  • Sector
  • PCYO Utilities
  • LUNG Health Care
  • Exchange
  • PCYO Nasdaq
  • LUNG Nasdaq
  • Market Cap
  • PCYO 258.3M
  • LUNG 248.0M
  • IPO Year
  • PCYO N/A
  • LUNG 2020
  • Fundamental
  • Price
  • PCYO $10.62
  • LUNG $7.01
  • Analyst Decision
  • PCYO
  • LUNG Strong Buy
  • Analyst Count
  • PCYO 0
  • LUNG 7
  • Target Price
  • PCYO N/A
  • LUNG $13.71
  • AVG Volume (30 Days)
  • PCYO 40.6K
  • LUNG 240.7K
  • Earning Date
  • PCYO 11-13-2024
  • LUNG 10-28-2024
  • Dividend Yield
  • PCYO N/A
  • LUNG N/A
  • EPS Growth
  • PCYO N/A
  • LUNG N/A
  • EPS
  • PCYO 0.25
  • LUNG N/A
  • Revenue
  • PCYO $19,555,000.00
  • LUNG $76,583,000.00
  • Revenue This Year
  • PCYO N/A
  • LUNG $22.73
  • Revenue Next Year
  • PCYO N/A
  • LUNG $19.02
  • P/E Ratio
  • PCYO $42.87
  • LUNG N/A
  • Revenue Growth
  • PCYO N/A
  • LUNG 26.26
  • 52 Week Low
  • PCYO $8.94
  • LUNG $5.46
  • 52 Week High
  • PCYO $11.32
  • LUNG $14.84
  • Technical
  • Relative Strength Index (RSI)
  • PCYO 52.40
  • LUNG 37.20
  • Support Level
  • PCYO $10.50
  • LUNG $7.18
  • Resistance Level
  • PCYO $10.89
  • LUNG $7.47
  • Average True Range (ATR)
  • PCYO 0.33
  • LUNG 0.40
  • MACD
  • PCYO -0.02
  • LUNG -0.18
  • Stochastic Oscillator
  • PCYO 23.91
  • LUNG 5.32

About PCYO Pure Cycle Corporation

Pure Cycle Corp is a diversified land and water resource development company. It designs, constructs, manages, operates, and maintains water and wastewater systems. The firm operates in two business segments namely Water and wastewater resource development and Land development. It generates maximum revenue from the Land development segment. The company's services include water production, storage, treatment, bulk transmission to retail distribution systems, wastewater collection and treatment, irrigation water treatment and transmission, construction management, billing, and collection. The land resource development segment includes all the activities necessary to develop and sell finished lots.

About LUNG Pulmonx Corporation

Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). The company's solutions are comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the United States which a key revenue generating market, Europe, Middle-East and Africa, Asia Pacific and other regions.

Share on Social Networks: